RAPT

RAPT Therapeutics, Inc.NASDAQHealthcare

$58.01+0.00%ClosedMarket Cap: $959.3M

As of 2026-04-04

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-01-21	Leerink Partners	—	Market Perform	—
2026-01-21	Barclays	—	Equal Weight	—
2026-01-20	TD Cowen	—	Hold	—
2026-01-20	Clear Street	—	Hold	—
2026-01-20	Wells Fargo	—	Equal Weight	—
2026-01-20	LifeSci Capital	—	Market Perform	—
2026-01-20	HC Wainwright & Co.	—	Neutral	—
2025-11-12	JP Morgan	—	Overweight	—
2025-11-07	Barclays	—	Overweight	—
2025-11-03	Wells Fargo	—	Overweight	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Thu Dec 31	$-3.17	$10.2M	4
Fri Dec 31	$-3.71	$805.4K	3
Sun Dec 31	$-4.80	$83.7M	3
Mon Dec 31	$-6.47	$18.1M	1